Do You Want To Become A Trustee?

16th July 2021


Cure Leukaemia is looking for new Trustees to take us forward as a leading national blood cancer charity. If you are interest and feel you could play your part in our quest to eradicate blood cancer please take a look at our information pack below and get in touch if you would like to discuss this further.

DOWNLOAD INFORMATION PACK

We are particularly looking for Trustees with knowledge and expertise in the following 3 areas:

·         Human Resources

·         Diversity & Inclusion / Equal Opportunities

·         Media / Communications

​We are also keen to recruite Trustees from across the whole United Kingdom to reflect Cure Leukaemia's nationwide impact since we began funding the Trials Acceleration Programme (TAP) in January 2020.


Why become a Trustee? 

Trustees play a significant role in shaping and leading our national organisation. In January 2020, Cure Leukaemia began a 3-year £3,000,000 commitment to funding the national Trials Acceleration Programme (TAP). This network comprising of specialist research nurses based in 13 of the UK’s biggest hospitals, gives blood cancer patients from a catchment area of over 20 million people access  to potentially lifesaving treatments through clinical trials. These trials are not currently available through standard NHS care for blood cancer. We value greatly the experience, expertise and commitment our Trustees bring, without remuneration and purely in the interests of the charity on an unpaid basis. 
Being a Trustee offers you the opportunity to: 

• use your skills and experience effectively
• improve personal networks
• develop new skills and knowledge
• Enhance the national awareness and impact of the charity
• get involved in the local community, and crucially;
• make a positive difference


Cure Leukaemia is currently looking to refresh, develop and further strengthen its Board of Trustees: the briefing pack is designed to help you participate fully in our selection and appointment process, and to provide you with all the information you need in order to understand how you meet the requirements of the role. We strongly advise that you read these notes thoroughly before making an application. 

After reading this information, we hope you will feel encouraged to apply to become a Trustee and in doing so, give yourself an opportunity to make a significant contribution to our charity. 

If you would like an informal and confidential discussion about becoming a Trustee, please contact Geoff Cousins (Chairman) or James McLaughlin (Chief Executive) via email: geoff.cousins@cureleukaemia.co.uk / james@cureleukaemia.co.uk 

 

Cure Leukaemia’s funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies through the delivery of practice informing clinical trials which not only saves lives but also increases investment into this country’s economy.

 

We have seen the urgent importance of clinical trials to combat the COVID-19 virus and we must not lose sight of the transformative role networks like TAP play in connecting blood cancer patients in the UK with critically important clinical trials. The vaccines currently being used to combat the coronavirus would normally take up to 8 years to develop and yet, through clinical trials and world class science this was accelerated to just 8 months.

 

This highlights the rapid progress that can be made through clinical trial networks, and I would certainly recommend Cure Leukaemia as a charity for the Trustees of the Garfield Weston Foundation to consider supporting because its work is of vital importance to blood cancer patients across the UK.

 

Professor Sir John Bell, Regius Professor of Medicine at the University of Oxford, and member of the Government’s COVID-19 vaccine taskforce

< Back to List

What we do

The Trials Acceleration Programme (TAP)

How funds raised for Cure Leukaemia help save lives

Cure Leukamia Pre footer image
"Cure Leukaemias funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell
"Cure Leukaemias funding of the UK Trials Acceleration Programme (TAP) is a game-changer and increases the access for blood cancer patients to potentially transformative new therapies."

Sir John Bell